A Study to Evaluate the Efficacy and Safety of Serplulimab in Combination With Chemotherapy and Concurrent Radiotherapy in Patients With Limited-Stage Small Cell Lung Cancer
Clinical trial NCT05353257 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05353257
- Sponsor
- Shanghai Henlius Biotech
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-17
- Primary completion
- 2026-06-30
- Enrollment
- 511
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.